Epidermal growth factor receptor targeting in cancer.

By J. Mendelsohn, J. Baselga. Seminars in Oncology, 2006

740 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/8f5a395b75760cbc63841cf19de71aed28fcca1f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. C. Der
2. P. Roberts

In Oncology

1. William Pao
2. C. Der
3. J. Chmielecki
4. P. Roberts

In Pulmonary and Respiratory Medicine

1. J. Chmielecki
2. William Pao
3. C. Der
4. P. Roberts

Citations in the corpus

• Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer (2007, background): “The EGFR family consists of four transmembrane receptors: EGFR (HER1/erbB-1), HER2 (erbB-2/neu), HER3 (erbB-3) and HER4 (erbB-4) (Mendelsohn and Baselga, 2006; Scaltriti and Baselga, 2006).”
• Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer (2010, background): “Cetuximab is a human–murine chimeric IgG1 monoclonal antibody that binds to the extracellular domain of EGFR and blocks EGFR signallin”